Unhandled Error

Error Details

File
Error  Could not allocate space for object 'dbo.EventLog'.'PK_EventLogMaster' in database 'HelicosDNN' because the 'PRIMARY' filegroup is full. Create disk space by deleting unneeded files, dropping objects in the filegroup, adding additional files to the filegroup, or setting autogrowth on for existing files in the filegroup.


Management and Senior Advisors

Mr. Jeffrey R. Moore
Senior Vice President and Chief Financial Officer
Jeffrey Moore

Mr. Moore joined Helicos in August 2009, bringing over 20 years of financial experience in life science technology and Big 4 accounting. He has a demonstrated track record of success in guiding leading edge strategic and operational initiatives that directly impact top line and bottom line results.

Previously, Mr. Moore was managing member and founder of Fiske Pond Advisors LLC, a financial advisory services firm, since 2008. Mr. Moore served as Chief Financial Officer of Affinova, Inc., a privately-held innovation technology company, from 2004 to 2008 and Vice President of Finance at Flagship Ventures from 2000 to 2006. He served as the Director of Business Analysis and Planning at Celera Genomics, the first biotechnology firm to sequence the human genome, from 1998 to 1999. Prior to Celera, Mr. Moore was Vice President of Treasury Operations at a public life science technology company, PerSeptive Biosystems.

Mr. Moore received his BS degree from Cornell University and MBA from Vanderbilt University.

Dr. Patrice M. Milos
Senior Scientific Advisor
Patrice Milos

Dr. Milos joined Helicos in June 2007. Her expertise and extensive knowledge in the life sciences advances the company's efforts to develop innovative and breakthrough technology. She previously served as Executive Director at Pfizer Global Research and Development, where she was responsible for leadership, strategic alignment and execution of the scientific disciplines of pharmacogenomics, proteomics, metabonomics and RNA profiling across the Pfizer portfolio from early discovery into the marketplace. She joined Pfizer in 1993 and held numerous research positions of increasing responsibility focusing on Cardiovascular and Metabolic Disease, Pharmacogenomics, DNA Sequencing, Biomarkers and Molecular Sciences.

Dr. Milos serves on the National Advisory Council for Human Genome Research and was pivotal in the establishment and oversight of key Pfizer strategic investments in the genomics area, most notably, the Genetic Association Information Network. She also sits on several editorial boards for journals and has published and presented extensively in the genomics area. Dr. Milos conducted post-doctoral fellowships at Brown University and Harvard University. She earned her MS and PhD degrees at Rensselear Polytechnic Institute in Troy, NY and received her BA from The College of Saint Rose in Albany, NY.


HLCS (OT)   Nov 21, 2012

$0.01         0.00           -

Quotes delayed at least 20 minutes. Information provided by eSignal.

Email alerts sign-up
Fine-tune the emails you receive from Helicos Biosciences Corporation with specific SEC filing types, news types, and stock price changes. Choose to receive the closing stock price each day, or a summary of stock prices at the end of the week.

Sign-up now


RSS news feed sign-up.
Subscribe to RSS news feeds to automatically be notified of SEC filings and news releases.

Sign-up now


Search Investor Relations.
  Investor site
  Section only